VBI Vaccines (VBIV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
At VBI Vaccines’ Annual General Meeting, shareholders represented nearly half of the company’s outstanding shares, reaffirming their support by re-electing all eight director nominees with a high percentage of votes in favor. Additionally, the shareholders voted to appoint EisnerAmper LLP as the independent registered public accounting firm for the upcoming year. VBI Vaccines continues to focus on powerful disease prevention and treatment, leveraging its innovative virus-like particle technologies.
For further insights into VBIV stock, check out TipRanks’ Stock Analysis page.
